|
"楊志新"的相关文件
显示项目 11-35 / 209 (共9页)
1 2 3 4 5 6 7 8 9 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2018-09-10T15:17:53Z |
Treating patients with ALK -positive non-small cell lung cancer: Latest evidence and management strategy
|
Liao, B.-C. and Lin, C.-C. and Shih, J.-Y. and Yang, J.C.-H.; Liao, Bin-Chi;Lin, Chia-Chi;Shih, Jin-Yuan;Yang, James Chih-Hsin; 林家齊;楊志新;廖斌志;施金元; 林家齊;楊志新;廖斌志;施金元; Liao, Bin-Chi; Lin, Chia-Chi; Shih, Jin-Yuan; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2018-09-10T15:17:53Z |
Rapid Response to Sunitinib in a Patient with Lung Adenocarcinoma Harboring KIF5B-RET Fusion Gene
|
Wu, H. and Shih, J.-Y. and Yang, J.C.-H.; Wu, Hsu;Shih, Jin-Yuan;Yang, James Chih-Hsin; Wu, Hsu;Shih, Jin-Yuan;Yang, James Chih-Hsin; 楊志新;施金元; Wu, Hsu; JIN-YUAN SHIH; Shih, Jin-Yuan; Shih, Jin-Yuan; Yang, James Chih-Hsin; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2018-09-10T15:17:38Z |
High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country
|
Chen, Wei-Wu; Chen, I-Chun; Wu, Pei-Fang; Wu, Pei-Fang; Kuo, Sung-Hsin; Kuo, Sung-Hsin; Chen, Chien-Jen; Chen, Chien-Jen; Lu, Yen-Shen; Lu, Yen-Shen; Cheng, Ann-Lii; Lin, Ching-Hung;Shen, Chen-Yang;Lee, Jih-Hsiang;Huang, Chiun-Sheng;Yang, Chih-Hsin;Kuo, Wen-Hung;Chang, Dwan-Ying;Hsiung, Chia-Ni;Kuo, Kuan-Ting;Chen, Wei-Wu;Chen, I-Chun;Wu, Pei-Fang;Kuo, Sung-Hsin;Chen, Chien-Jen;Lu, Yen-Shen;Cheng, Ann-Lii; Lin, Ching-Hung;Shen, Chen-Yang;Lee, Jih-Hsiang;Huang, Chiun-Sheng;Yang, Chih-Hsin;Kuo, Wen-Hung;Chang, Dwan-Ying;Hsiung, Chia-Ni;Kuo, Kuan-Ting;Chen, Wei-Wu;Chen, I-Chun;Wu, Pei-Fang;Kuo, Sung-Hsin;Chen, Chien-Jen;Lu, Yen-Shen;Cheng, Ann-Lii; Ching-Hung Lin and Chen-Yang Shen and Jih-Hsiang Lee and Chiun-Sheng Huang and Chih-Hsin Yang and Wen-Hung Kuo and Dwan-Ying Chang and Chia-Ni Hsiung and Kuan-Ting Kuo and Wei-Wu Chen and I-Chun Chen and Pei-Fang Wu and Sung-Hsin Kuo and Chien-Jen Chen and Yen-Shen Lu and Ann-Lii Cheng; 林志弘;楊志新;陳偉武;郭文宏;盧彥伸;林璟宏;陳怡君;郭冠廷;郭頌鑫;吳佩芳;鄭安理;黃俊升;張端瑩;李日翔;林季宏; 林志弘;楊志新;陳偉武;郭文宏;盧彥伸;林璟宏;陳怡君;郭冠廷;郭頌鑫;吳佩芳;鄭安理;黃俊升;張端瑩;李日翔;林季宏; Lin, Ching-Hung; Lin, Ching-Hung; CHIUN-SHENG HUANG; Sung-Hsin Kuo; Shen, Chen-Yang; Chiang, I-Ni; CHING-HUNG LIN; Lee, Jih-Hsiang; Lee, Jih-Hsiang; Huang, Chiun-Sheng; KUAN-TING KUO; Huang, Chiun-Sheng; Yang, Chih-Hsin; ANN-LII CHENG; Yang, Chih-Hsin; Kuo, Wen-Hung; Kuo, Wen-Hung; Chang, Dwan-Ying; Chang, Dwan-Ying; Hsiung, Chia-Ni; Hsiung, Chia-Ni; Kuo, Kuan-Ting; Kuo, Kuan-Ting; Chen, Wei-Wu |
| 臺大學術典藏 |
2018-09-10T15:17:32Z |
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
|
Tsai, Tzu-Hsiu;Wu, Shang-Gin;Hsieh, Min-Shu;Yu, Chong-Jen;Yang, James Chih-Hsin;Shih, Jin-Yuan; Tsai, Tzu-Hsiu;Wu, Shang-Gin;Hsieh, Min-Shu;Yu, Chong-Jen;Yang, James Chih-Hsin;Shih, Jin-Yuan; Tsai, T.-H. and Wu, S.-G. and Hsieh, M.-S. and Yu, C.-J. and Yang, J.C.H. and Shih, J.-Y.; 楊志新;余忠仁;謝明書;吳尚俊;蔡子修;施金元; MIN-SHU HSIEH; Tsai, Tzu-Hsiu; CHONG-JEN YU; Wu, Shang-Gin; Hsieh, Min-Shu; JIN-YUAN SHIH; Hsieh, Min-Shu; Yu, Chong-Jen; CHIH-HSIN YANG; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, James Chih-Hsin; Shih, Jin-Yuan; Shih, Jin-Yuan |
| 臺大學術典藏 |
2018-09-10T14:49:59Z |
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations
|
Chen, Yen-Fu;Hsieh, Min-Shu;Wu, Shang-Gin;Chang, Yih-Leong;Shih, Jin-Yuan;Liu, Yi-Nan;Tsai, Meng-Feng;Tsai, Tzu-Hsiu;Yu, Chong-Jen;Yang, James Chih-Hsin;Yang, Pan-Chyr; Chen, Y.-F. and Hsieh, M.-S. and Wu, S.-G. and Chang, Y.-L. and Shih, J.-Y. and Liu, Y.-N. and Tsai, M.-F. and Tsai, T.-H. and Yu, C.-J. and Yang, J.C.-H. and Yang, P.-C.; 楊志新;張逸良;楊泮池;余忠仁;謝明書;吳尚俊;陳瑛芳;蔡子修;施金元; 楊志新;張逸良;楊泮池;余忠仁;謝明書;吳尚俊;陳瑛芳;蔡子修;施金元; MIN-SHU HSIEH; Chen, Yen-Fu; Hsieh, Min-Shu; YIH-LEONG CHANG; Wu, Shang-Gin; CHONG-JEN YU; JIN-YUAN SHIH; Chang, Yih-Leong; CHIH-HSIN YANG; Shih, Jin-Yuan; Liu, Yi-Nan; Tsai, Meng-Feng; Tsai, Tzu-Hsiu; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr |
| 臺大學術典藏 |
2018-09-10T09:41:46Z |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
楊泮池; Wu, S.-G. and Yu, C.-J. and Tsai, M.-F. and Liao, W.-Y. and Yang, C.-H. and Jan, I.-S. and Yang, P.-C. and Shih, J.-Y.; Wu, Shang-Gin;Yu, Chong-Jen;Tsar, Meng-Feng;Liao, Wei-Yu;Yang, Chih-Hsin;Jan, I-Shiow;Yang, Pan-Chyr;Shin, Jin-Yuan; 楊志新 ;詹一秀 ;楊泮池 ;廖唯昱 ;余忠仁; 楊志新 ;詹一秀 ;楊泮池 ;廖唯昱 ;余忠仁; Wu, Shang-Gin; WEI-YU LIAO; Wu, Shang-Gin; Chong-Jen Yu; Yu, Chong-Jen; Yu, Chong-Jen; Tsar, Meng-Feng; JIN-YUAN SHIH; Liao, Wei-Yu; Liao, Wei-Yu; I-SHIOW JAN; Yang, Chih-Hsin; Yang, Chih-Hsin; Jan, I-Shiow; Jan, I-Shiow; Yang, Pan-Chyr; Yang, Pan-Chyr; Shin, Jin-Yuan |
| 臺大學術典藏 |
2018-09-10T09:15:12Z |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
Chang, Yeun-Chung; Yu, Chong-Jen; Chen, Chung-Ming; Hu, Fu-Chang; Hsu, Hao-Hsiang; Tseng, Wen-Yih I.; Shih, Tiffany Ting-Fang; Yang, Pan-Chyr; Yang, James Chih-Hsin曾文毅; 楊志新; 陳中明; 張允中; 施庭芳; 楊泮池; 余忠仁; 胡賦強; 曾文毅; 楊志新; 陳中明; 張允中; 施庭芳; 楊泮池; 余忠仁; 胡賦強Chang, Y.-C.; Yu, C.-J.; Chen, C.-M.; Hu, F.-C.; Hsu, H.-H.; Tseng, W.-Y.I.; Ting-Fang Shih, T.; Yang, P.-C.; Chih-Hsin Yang, J.; 楊泮池; Chang, Yeun-Chung; TIFFANY TING-FANG SHIH; Yu, Chong-Jen; Chen, Chung-Ming; CHONG-JEN YU; Yang, Pan-Chyr |
| 臺大學術典藏 |
2018-09-10T09:13:20Z |
EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR
|
JIN-YUAN SHIH; Chang, Yih-Leong; Shih, Jin-Yuan; Chen, Ya-Hui; Tsai, Meng-Feng; Yu, Chong-Jen; Yang, Chih-Hsin; Yang, Pan-Chyr; 陳盈憲; Wu, S.-G. and Kuo, Y.-W. and Chang, Y.-L. and Shih, J.-Y. and Chen, Y.-H. and Tsai, M.-F. and Yu, C.-J. and Yang, C.-H. and Yang, P.-C.; Wu, Shang-Gin;Kuo, Yao-Wen;Chang, Yih-Leong;Shih, Jin-Yuan;Chen, Ya-Hui;Tsai, Meng-Feng;Yu, Chong-Jen;Yang, Chih-Hsin;Yang, Pan-Chyr; 楊志新 ;張逸良 ;楊泮池 ;余忠仁 ;郭耀文 ;吳尚俊 ;施金元 ;陳盈憲; YIH-LEONG CHANG; Wu, Shang-Gin; Kuo, Yao-Wen; Chong-Jen Yu |
| 臺大學術典藏 |
2018-09-10T09:13:19Z |
Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors
|
Hsu, Chia-Lin;Chen, Kuan-Yu;Shih, Jin-Yuan;Ho, Chao-Chi;Yang, Chih-Hsin;Yu, Chong-Jen;Yang, Pan-Chyr; Hsu, C.-L. and Chen, K.-Y. and Shih, J.-Y. and Ho, C.-C. and Yang, C.-H. and Yu, C.-J. and Yang, P.-C.; 楊志新 ;楊泮池 ;許嘉林 ;陳冠宇 ;余忠仁 ;何肇基 ;施金元; Chong-Jen Yu; Hsu, Chia-Lin; Chen, Kuan-Yu; CHIA-LIN HSU; CHAO-CHI HO; Shih, Jin-Yuan; JIN-YUAN SHIH; Ho, Chao-Chi; Yang, Chih-Hsin; Yu, Chong-Jen; Yang, Pan-Chyr |
| 臺大學術典藏 |
2018-09-10T06:48:43Z |
Recurrent advancing wavelike epitheliopathy from the opposite side of the initial presentation
|
FUNG-RONG HU; Chu, HS; Wu, Shang-Gin; I-JONG WANG; Hu, FR; Chang, Yih-Leong; Wang, IJ; Shih, Jin-Yuan; Hou, YC; Chen, WL.; Liu, Yi-Nan; Tsai, Meng-Feng; Tsai, Tzu-Hsiu; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr; 楊志新; 張逸良; 楊泮池; 余忠仁; 謝明書; 吳尚俊; 陳瑛芳; 蔡子修; 施金元; Hsieh, Min-Shu; Chen, Yen-Fu; WEI-LI CHEN; Huang, YH; HUANG, YU-HSUN;CHU, HSIAO-SANG;HU, FUNG -RONG;WANG, I-JONG;HOU, YU-CHI;CHEN, WEI-LI; 黃昱勳;朱筱桑;胡芳蓉;王一中;侯鈺琪;陳偉勵; Huang, Y.-H. and Chu, H.-S. and Hu, F.-R. and Wang, I.-J. and Hou, Y.-C. and Chen, W.-L.; Huang, YH;Chu, HS;Hu, FR;Wang, IJ;Hou, YC;Chen, WL. |
| 國立成功大學 |
2018 |
以溝通指引落實癌症臨床試驗知情同意並提升病人自主決策能力：瞭解影響因素、指引建立與評價成效
|
高綺吟;黃美智;蘇五洲;胡文郁;楊志新;方素瓔 |
| 國立臺灣大學 |
2016 |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
|
Wu, Shang-Gin; Liu, Yi-Nan; Tsai, Meng-Feng; Chang, Yih-Leong; Yu, Chong-Jen; Yang, Pan-Chyr; Yang, James Chih-Hsin; Wen, Yueh-Feng; Shih, Jin-Yuan; 楊志新; 張逸良; 楊泮池; 余忠仁; 溫岳峰; 吳尚俊; 施金元 |
| 國立臺灣大學 |
2016 |
Efficacy of of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations
|
Chen, Yen-Fu; Hsieh, Min-Shu; Wu, Shang-Gin; Chang, Yih-Leong; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr; Shih, Jin-Yuan; 楊志新; 張逸良; 楊泮池; 余忠仁; 謝明書; 吳尚俊; 陳瑛芳; 施金元 |
| 國立臺灣大學 |
2016 |
Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors
|
Liao, Bin-Chi; Lin, Chia-Chi; Lee, Jih-Hsiang; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志; 李日翔 |
| 國立臺灣大學 |
2016 |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
Chen, Li-Yang; Molina-Vila, Miguel A.; Ruan, Sheng-Yuan; Su, Kang-Yi; Liao, Wei-Yu; Yu, Kai-Lun; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin; Rosell, Rafael; Yang, Pan-Chyr; 楊志新; 蘇剛毅; 廖唯昱; 余忠仁; 何肇基; 阮聖元; 施金元 |
| 國立臺灣大學 |
2016 |
Safety of gefitinib in non-small cell lung cancer treatment
|
Hsiue, Emily Han-Chung; Lee, Jih-Hsiang; Lin, Chia-Chi; Yang, James Chih-Hsin; 林家齊; 楊志新; 李日翔 |
| 國立臺灣大學 |
2016 |
Time to response in patients with ALK plus NSCLC receiving alectinib in the phase II NP28673 and NP28761 studies
|
Gandhi, L.; Gadgeel, S.; Shaw, A.; Barlesi, F.; Crino, L.; Yang, J. C-H.; Dingemans, A-M. C.; Kim, D-W.; de Marinis, F.; Schulz, M.; Liu, S.; Fish, S.; Kotb, A.; Ou, S-H. I.; 楊志新 |
| 國立臺灣大學 |
2016 |
Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice
|
Liang, Yi-Hsin; Shao, Yu-Yun; Liao, Bin-Chi; Lee, Ho-Sheng; Yang, James Chih-Hsin; Chen, Ho-Min; Chiang, Chun-Ju; Cheng, Ann-Lii; Lai, Mei-Shu; 梁逸歆; 楊志新; 邵幼雲; 廖斌志; 賴美淑; 鄭安理 |
| 國立臺灣大學 |
2016 |
Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non-Small-Cell Lung Cancer: Analysis and Literature Review
|
Lin, Yen-Ting; Yu, Chong-Jen; Yang, James Chih-Hsin; Shih, Jin-Yuan; 楊志新; 余忠仁; 林奕廷; 林怡岑; 施金元 |
| 國立臺灣大學 |
2016 |
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
|
Schuler, M.; Yang, J. C. -H.; Park, K.; Kim, J. -H.; Bennouna, J.; Chen, Y. -M.; Chouaid, C.; De Marinis, F.; Feng, J. -F.; Grossi, F.; Kim, D. -W.; Liu, X.; Lu, S.; Strausz, J.; Vinnyk, Y.; Wiewrodt, R.; Zhou, C.; Wang, B.; Chand, V. K.; Planchard, D.; 楊志新 |
| 國立臺灣大學 |
2016 |
Profile of the therascreen (R) EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancer
|
Hsiue, Emily Han-Chung; Lee, Jih-Hsiang; Lin, Chia-Chi; Yang, James Chih-Hsin; 林家齊; 楊志新; 李日翔 |
| 臺大學術典藏 |
2016 |
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
|
Schuler, M.;Yang, J. C. -H.;Park, K.;Kim, J. -H.;Bennouna, J.;Chen, Y. -M.;Chouaid, C.;De Marinis, F.;Feng, J. -F.;Grossi, F.;Kim, D. -W.;Liu, X.;Lu, S.;Strausz, J.;Vinnyk, Y.;Wiewrodt, R.;Zhou, C.;Wang, B.;Chand, V. K.;Planchard, D.; 楊志新; Schuler, M.; Yang, J. C. -H.; Park, K.; Kim, J. -H.; Bennouna, J.; Chen, Y. -M.; Chouaid, C.; De Marinis, F.; Feng, J. -F.; Grossi, F.; Kim, D. -W.; Liu, X.; Lu, S.; Strausz, J.; Vinnyk, Y.; Wiewrodt, R.; Zhou, C.; Wang, B.; Chand, V. K.; Planchard, D. |
| 國立臺灣大學 |
2015 |
High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country
|
Lin, Ching-Hung; Shen, Chen-Yang; Lee, Jih-Hsiang; Huang, Chiun-Sheng; Yang, Chih-Hsin; Kuo, Wen-Hung; Chang, Dwan-Ying; Hsiung, Chia-Ni; Kuo, Kuan-Ting; Chen, Wei-Wu; Chen, I-Chun; Wu, Pei-Fang; Kuo, Sung-Hsin; Chen, Chien-Jen; Lu, Yen-Shen; Cheng, Ann-Lii; 林志弘; 楊志新; 陳偉武; 郭文宏; 盧彥伸; 林璟宏; 陳怡君; 郭冠廷; 郭頌鑫; 吳佩芳; 鄭安理; 黃俊升; 張端瑩; 李日翔; 林季宏 |
| 國立臺灣大學 |
2015 |
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
|
Tsai, Tzu-Hsiu; Wu, Shang-Gin; Hsieh, Min-Shu; Yu, Chong-Jen; Yang, James Chih-Hsin; Shih, Jin-Yuan; 楊志新; 余忠仁; 謝明書; 吳尚俊; 蔡子修; 施金元 |
| 國立臺灣大學 |
2015 |
Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways
|
Lai, Yi-Hua; Chen, Min-Hsuan; Lin, Sih-Yin; Lin, Sheng-Yi; Wong, Yung-Hao; Yu, Sung-Liang; Chen, Huei-Wen; Yang, Chih-Hsin; Chang, Gee-Chen; Chen, Jeremy J. W.; 楊志新; 俞松良; 陳惠文 |
显示项目 11-35 / 209 (共9页)
1 2 3 4 5 6 7 8 9 > >>
每页显示[10|25|50]项目
|
